Glucose-6-Phosphate Isomerase (GPI) Peptide
Quick Overview for Glucose-6-Phosphate Isomerase (GPI) Peptide (ABIN937654)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- EALMRGKSTE EARKELQAAG KSPEDLERLL PHKVFEGNRP TNSIVFTKLT
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GPI antibody,
Alternative Names: GPI control peptide, GPI antibody Blocking Peptide, Anti-GPI Blocking Peptide, glucose-6-phosphate isomerase Blocking Peptide, AMF Blocking Peptide, GNPI Blocking Peptide, NLK Blocking Peptide, PGI Blocking Peptide, PHI Blocking Peptide, SA36 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- GPI (Glucose-6-Phosphate Isomerase (GPI))
-
Target Type
- Viral Protein
-
Background
- This gene belongs to the GPI family whose members encode multifunctional phosphoglucose isomerase proteins involved in energy pathways. The protein encoded by this gene is a dimeric enzyme that catalyzes the reversible isomerization of glucose-6-phosphate and fructose-6-phosphate. The protein functions in different capacities inside and outside the cell. In the cytoplasm, the gene product is involved in glycolysis and gluconeogenesis, while outside the cell it functions as a neurotrophic factor for spinal and sensory neurons. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment.
-
Molecular Weight
- 63 kDa
Target
-